CB Insights
Technology Market Intelligence
Technology Market Intelligence
Public list: Pharma Startups (6570) Neuroscience Startups (947)
Alzheon is an American clinical-stage biopharmaceutical company based in Framingham, Massachusetts. The company develops medicines for patients suffering from Alzheimer's disease and other neurological and psychiatric disorders.
Company (Alive / Active)
Phone: 508-681-7709
111 Speen Street
Suite 306
Framingham, 01701
Massachusetts, United States
| Per Week | Per Month | Per 6 Months | Per Year | |
|---|---|---|---|---|
| Rank | Login to see details | |||
| Page Views Per Million | Login to see details | |||
| Page Views Per User | Login to see details | |||
| Reach Per Million | Login to see details | |||
| Investor | Investor Type | Location | Participating Rounds |
|---|
| Name | Firm |
|---|---|
| Login to see details | Ally Bridge Group |
| Title | Application Date | Patent Date | Status (Patent / Application) |
|---|---|---|---|
| Compositions and methods for treating and preventing neurodegenerative disorders | Aug 10, 2016 | Mar 17, 2020 | Patent |
| Methods for treating neurological disorders | Mar 23, 2015 | Nov 12, 2019 | Patent |
| Compositions and methods for treating and preventing neurodegenerative disorders | Mar 03, 2020 | Application | |
| Methods for treating neurological disorders | Sep 13, 2019 | Application | |
| Methods for treating neurodegenerative disorders | Feb 23, 2018 | Application |
